Inherent Biosciences, Inc. — Form D

Inherent Biosciences, Inc. of SALT LAKE CITY, UT, a company, filed a Form D exempt-offering notice with the SEC on 2023-05-31. $1.5M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2023-05-31
• Form: D
• Accession: 0001977505-23-000001
• Industry: Biotechnology
• Exemptions: 06b
• Amount sold: $1.5M
• Investors: 12
• Date of first sale: 2022-08-19
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-483042

Issuer

• Name: Inherent Biosciences, Inc.
• CIK: 0001977505
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2019
• Address: 26 S RIO GRANDE STREET #2072, SALT LAKE CITY, UT, 84101
• Phone: 509-496-1204

Officers, directors & promoters (1)

More

• CIK 1977505 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search